Since a reduced FA oxidation capacity causes energy starvation in a failing heart, modulating the technology of TEFA transport via several possible pathways, including PPARγ, Notch, and Meox2/TCF15, might open a new avenue to developing therapeutic strategies for energy-starved heart failure. This evidence concerns the gene MEOX2 and heart failure.